YS Biopharma (YSBPW) Competitors $0.01 0.00 (0.00%) As of 09/19/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock YSBPW vs. ATNFW, SXTPW, DRTSW, APLMW, BCTXW, CDIOW, CELUW, CEROW, CINGW, and CLNNWShould you be buying YS Biopharma stock or one of its competitors? The main competitors of YS Biopharma include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Celularity (CELUW), CERo Therapeutics (CEROW), Cingulate (CINGW), and Clene (CLNNW). These companies are all part of the "biotechnology" industry. YS Biopharma vs. Its Competitors 180 Life Sciences 60 Degrees Pharmaceuticals Alpha Tau Medical Apollomics BriaCell Therapeutics Cardio Diagnostics Celularity CERo Therapeutics Cingulate Clene 180 Life Sciences (NASDAQ:ATNFW) and YS Biopharma (NASDAQ:YSBPW) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, profitability, dividends, valuation, analyst recommendations, earnings and media sentiment. Does the media refer more to ATNFW or YSBPW? In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled YS Biopharma'saverage media sentiment score. Company Overall Sentiment 180 Life Sciences Neutral YS Biopharma Neutral Is ATNFW or YSBPW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A YS Biopharma N/A N/A N/A Which has better earnings and valuation, ATNFW or YSBPW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/AYS Biopharma$560.76MN/AN/AN/AN/A SummaryYS Biopharma beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks. Get YS Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for YSBPW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart YSBPW vs. The Competition Export to ExcelMetricYS BiopharmaBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$224.15M$6.13B$10.47BDividend YieldN/A3.81%5.73%4.78%P/E RatioN/A99.5085.1527.20Price / SalesN/A5,903.80575.35178.82Price / CashN/A13.1937.3961.86Price / BookN/A99.1912.396.65Net IncomeN/A-$90.99M$3.32B$276.79M7 Day PerformanceN/A-0.32%-0.24%-1.51%1 Month PerformanceN/A6.04%9.56%5.45%1 Year PerformanceN/A669.41%71.67%36.24% YS Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)YSBPWYS BiopharmaN/A$0.01flatN/A-84.8%$0.00$560.76M0.00865Gap UpHigh Trading VolumeATNFW180 Life SciencesN/A$0.06-11.2%N/A+585.9%$0.00N/A0.007Gap DownSXTPW60 Degrees PharmaceuticalsN/A$0.04+6.7%N/A+96.8%$0.00$641.41K0.002News CoverageGap UpDRTSWAlpha Tau MedicalN/A$0.36+0.5%N/A+76.3%$0.00N/A0.0080Gap UpAPLMWApollomicsN/A$0.02flatN/A+138.0%$0.00N/A0.0059News CoveragePositive NewsShort Interest ↑BCTXWBriaCell TherapeuticsN/A$0.06-1.2%N/A-83.8%$0.00N/A0.008Positive NewsShort Interest ↑Gap DownCDIOWCardio DiagnosticsN/A$0.02-0.5%N/A-41.8%$0.00$19.51K0.007Positive NewsGap DownCELUWCelularityN/A$0.04+5.4%N/A+112.8%$0.00$44.59M0.00220Positive NewsShort Interest ↓Gap DownCEROWCERo TherapeuticsN/A$0.01+3.6%N/A+191.1%$0.00N/A0.008Positive NewsCINGWCingulateN/A$0.05-22.0%N/A-34.4%$0.00N/A0.0020Positive NewsCLNNWCleneN/A$0.02+2.6%N/A-74.5%$0.00$286K0.00100Positive NewsShort Interest ↓Gap Up Related Companies and Tools Related Companies 180 Life Sciences Alternatives 60 Degrees Pharmaceuticals Alternatives Alpha Tau Medical Alternatives Apollomics Alternatives BriaCell Therapeutics Alternatives Cardio Diagnostics Alternatives Celularity Alternatives CERo Therapeutics Alternatives Cingulate Alternatives Clene Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:YSBPW) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding YS Biopharma Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share YS Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
